Delivery Order SPE2DB20D3101-SPE2DB25FRGE5
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.88 firm fixed-price delivery order contract has an ultimate completion date of March 17, 2025. It is not designated as a set-aside contract. The contract is for the procurement of EMGALITY 120 MG/ML PENML, a pharmaceutical product. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, identified as SPE2DB20D2014|SPE2DB25FB51N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,651.20 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a period of performance through April 2, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,671.20, is a Delivery Order contract with a Firm Fixed Price pricing type. The award has an ultimate completion date of November 15, 2024 and covers the procurement of EMGALITY 120 MG/ML PENML. This contract does not have a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDXTJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,556.10 Firm Fixed Price Delivery Order contract is for the provision of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a period of performance through February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRRV1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,002.72, is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.52 Firm Fixed Price Delivery Order contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,729, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 31, 2024. The contract is for the provision of EMGALITY 120 MG/ML PENML, a pharmaceutical product. This award is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.64 firm-fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a medication. The contract has a period of performance through March 12, 2025 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,032.27 firm fixed price delivery order is for EMGALITY 120 MG/ML PENML, a medication, and has a completion date of March 31, 2025. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is a Firm Fixed Price Delivery Order for the supply of EMGALITY 120 MG/ML PENML. This contract is not associated with a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...